Chris Hillis: Reflections on My Term as President of the Canadian Hematology Society
Chris Hillis, Associate Professor at McMaster University, Former President of the Canadian Hematology Society, shared on LinkedIn:
”Sharing my reflection as I finish my term as President of the Canadian Hematology Society.
Hematology is, in many ways, a microcosm of medicine at its best.
It spans the full spectrum, from rare benign disorders to complex malignancies, from transfusion medicine to cutting-edge cellular therapies.
It is a discipline grounded equally in science and humanity, where laboratory insights translate directly to patient lives, often in profound and immediate ways.
Over the past years, it has been a privilege to witness the continued evolution of our field including new therapies, deeper biological understanding, and a growing national community committed to excellence, collaboration, and equity.
What has stood out most, however, is not just the pace of innovation, but the strength of our people.
Across Canada, hematologists are leading: in research, in clinical care, in education, and in advocacy. We are increasingly interconnected, increasingly collaborative, and increasingly intentional about the kind of community we are building.
It is in that spirit that I am especially pleased to pass the torch to Alina Gerrie (The University of British Columbia BC Cancer).
Alina brings a remarkable combination of clinical expertise, academic rigor, and thoughtful leadership.
She represents the best of Canadian hematology.
Alina is deeply grounded in patient care, actively engaged in advancing knowledge, and committed to mentorship and community-building. Her perspective from British Columbia adds further strength to our national voice, and I have no doubt that under her leadership, the Society will continue to grow.
The future of hematology in Canada is extraordinarily bright!
We are entering an era of precision medicine, of increasingly sophisticated therapeutics, and of expanding opportunities to improve outcomes across all domains of our specialty.
At the same time, we are being called to lead in new ways.
As hematologist we must address access, support trainees and early-career colleagues, and ensure that our systems evolve alongside our science.
I leave this role with confidence that CHS is well-positioned to meet these challenges and opportunities.
That confidence rests not only in Alina’s leadership, but in all of you who continue to define what it means to be a hematologist in Canada.
Thank you for the privilege of serving this community.
I look forward to supporting CHS in new ways and to watching its continued evolution in the years ahead.”
Stay updated with Hemostasis Today.
-
Apr 10, 2026, 17:59Michelle Leona Cecil: Representing Microhealth at The Coalition for Hemophilia B Annual Symposium
-
Apr 10, 2026, 17:47Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
-
Apr 10, 2026, 17:39Diverse Voices But Shared Mission – Day 1 of EHC Youth Leadership Workshop
-
Apr 10, 2026, 17:30Make Your Mark at the World Stroke Congress 2026 – World Stroke Organization
-
Apr 10, 2026, 17:23Sofie Abels: Implications for Targeted Screening for Thrombophilia in Young Stroke Patients
-
Apr 10, 2026, 17:08Armghan Ans: 3 Questions Worth Sitting with If You Work in Stroke AI
-
Apr 10, 2026, 17:03William Wallace: Vitamin C Is More Than ”Immune Support”
-
Apr 10, 2026, 16:58Wolfgang Miesbach: Greater Symptom Burden in Women with Bleeding Disorders – Insights from Irish Data
-
Apr 10, 2026, 16:50Leonardo Roever: Non-Pharmacological Approaches Lead in PSCI Treatment